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Abstract. The present study investigated the first interaction that occurs between the blastocyst and endometrium during
implantation. Given the ethical objections to studying implantation in humans, a mouse model was used to study the
dialogue between luteinising hormone (LH) and luteinising hormone receptor (LHCGR). Several studies performed on
LHCGR-knockout mice have generated controversy regarding the importance of the dialogue between LH and LHCGR
during implantation. There has been no demonstration of a bioactive LH-like signal produced by the murine blastocyst.
The first aim of the present study was to examine and quantify, using radioimmunoassay, the generation of a bioactive LH
signal by the murine blastocyst. We went on to examine and quantify endometrial Lhcgr expression to validate the mouse
model. Expression of LHCGR in mouse uteri was demonstrated using immunohistochemistry and western blot analysis.
To quantify the expression of Lh in the mouse blastocyst and Lhcgr in the endometrium, reverse transcription–polymerase
chain reaction (RT-PCR) and real-time quantitative (q) RT-PCR were performed. The results demonstrate that Lhcgr
expression in BALB/c mouse endometrial epithelium is increased at the time of implantation and indicate that LHCGR
may contribute to the implantation process. In support of this hypothesis, we identified a bioactive LH signal at the time of
murine blastocyst implantation.
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Introduction
Implantation is a very complex and coordinated process
whereby the trophoblast establishes close contact with a spe-
cialised tissue contributed by themother called the endometrium
(Aplin 2000; Aplin and Kimber 2004). Normal implantation is
required for a successful pregnancy. Specifically, the following
two fundamental conditions are essential: (1) the embryo must
undergo a series of complex developmental processes during its
transport through the Fallopian tube; and (2) in parallel, the
endometrium must achieve adequate receptive status, called the
‘implantation window’ (Psychoyos 1986), which is the optimal
period for embryo implantation (Lessey 2000; Sunder and
Lenton 2000). Both conditions are necessary to initiate intimate
dialogue between the blastocyst and the endometrium (Carson
et al. 2000; Paria et al. 2002). To date, the implantation window
has not been molecularly defined; however, several potentially
defining factors have been identified, including growth factors,
cytokines, hormones, extracellular matrix proteins and related
enzymes, which are collectively produced by embryonic and
maternal tissues of uterine and extrauterine origins (Ghosh and
Sengupta 1998; Norwitz et al. 2001; Pan et al. 2006). In addi-
tion, the opposing tissuemust express cognate receptors for each
of these molecules so that implantation cross-talk can occur.
Obviously, the study of implantation is not ethically possible in
humans and therefore has to be investigated indirectly through
the use of animal models or in vitro models. Therefore, small
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animal models with a short gestation that is molecularly similar
to that of human gestation and that can be manipulated geneti-
cally provide an ideal system in which to study the molecular
details of the implantation cascade.
At present, the implantation event itself is the only definitive
marker of the implantation window and is associated with the
appearance of human chorionic gonadotropin (hCG) in the
maternal bloodstream of humans. This hormone is a specific
embryonic mediator that announces the embryo’s presence to
the maternal organism. Transcription of hCG begins before
implantation (Jurisicova et al. 1999), as shown in a study in
which the hCG production in fluid that was removed from
in vitro-cultured embryos was detected as soon as 170 h after
insemination (Fishel et al. 1984). In addition, the results of
recent studies demonstrate that hCG plays a crucial role in
regulating endometrial cell differentiation and the implantation
process; it not only participates in these processes via its
endocrine role, but also in a paracrine manner at the maternal–
fetal interface (Han et al. 1999; Cameo et al. 2004; Afshar et al.
2007; Licht et al. 2007). Blastocyst hCG increases endometrial
secretion of proimplantatory leukaemia inhibitory factor (LIF;
Perrier d’Hauterive et al. 2004) and macrophage–colony stimu-
lating factor (M-CSF; Licht et al. 2001), increases stromal
COX2 (cyclo-oxygenase 2) expression (Han et al. 1996) and
reduces the expression of the decidual marker IGF-BP1 (insulin-
like growth factor binding protein 1) during the late secretory
phase (Licht et al. 2002; Fluhr et al. 2006). Blastocyst hCG also
increases the production of vascular endothelium growth factor
(VEGF) by the endometrial epithelium and stimulates endome-
trial angiogenesis, suggesting that hCG actively participates
in placental development (Zygmunt et al. 2002; Berndt
et al. 2006). Finally, the fetal allograft contributes to its toler-
ance by the competent maternal immune system via the FAS–
FAS ligand pro-apoptosis system (Kayisli et al. 2003), its
inhibitory actions on endometrial interleukin (IL)-6 (Perrier
d’Hauterive et al. 2004) and complement C3 and C4 factors
(Sherwin et al. 2007) and by stimulating maternal regulatory
T cells (Zenclussen et al. 2006). Another example of an immu-
nomodulatory property of hCG is its capacity to downregulate
effector cells, including T helper (TH) 1 cells, CD8þ T cells and
macrophages, and to increase the CD4þCD25þ/CD4þ T cell
ratio, as shown in non-obese diabetic (NOD) mice (Khan et al.
2001; Khil et al. 2007).
In contrast, the first maternal tissue encountered by the
embryo is the endometrial epithelium, which expresses the
LH/chorionic gonadotropin receptor (LHCGR; Perrier d’Hau-
terive et al. 2004). The LHCGR system was first described in
gonadal (ovaries and testis) and non-gonadal tissues in porcine
(Ziecik et al. 1986), rabbit (Jensen and Odell 1988) and murine
(Mukherjee et al. 1994) endometrium.
Together, these observations suggest that the LHCGR system
is intimately involved in implantation processes, particularly in
humans, where hCG is the specific embryo signal sent to the
mother. The cross-talk between hCG and the LHCGR is likely
critical for the early steps of implantation, but is very difficult to
study in humans for obvious ethical reasons. Therefore, the
importance of the LHCGR system during implantation processes
has been approached via a murine model.
Themain objective of the present studywas to investigate the
existence of LH–LHCGR dialogue at the maternal–fetal inter-
face during implantation in mice. The existence of this cross-
talk is crucial for the validation of the mouse model as a good
non-human implantation model for the study of LH–LHCGR
communication. Therefore, we first identified and quantified the
presence of an LH-like signal produced by themouse blastocyst.
We then demonstrated the bioactivity of this signal by assessing
the production of testosterone by Leydig cells. Finally, endome-
trial Lhcgr expression throughout the oestrous cycle of the
BALB/c mouse was examined and quantified to determine
whether higher Lhcgr expression corresponded to the supposed
period of embryo implantation. A comprehensive examination
of endometrial LHCGR expression in mice and identification of
a bioactive LH-like signal are crucial first steps to characterise
the LHCGR system in themouse andmay lead to the elucidation
of the regulatory pathways involved in the early adhesion and
invasion processes of implantation.
Materials and methods
Animals
BALB/cmice (5–12weeks old) andC57malemice (2–3months
old) were obtained from the University of Liege Animal Center
and investigations were conducted with the approval of the
University of Liege Ethics Committee for the care of experi-
mental animals (no. 2006/412 and no. 2006/561). Mice were
housed under a 12-h light–dark cycle in a temperature-
controlled environment,with food andwater available ad libitum.
Endometrial tissue or granulosa cells served as the positive
control for reverse transcription–polymerase chain reaction
(RT-PCR) and RNA samples were obtained from BALB/c
female mice. Testes and ovaries obtained from BALB/c mice
(5 weeks old) were used as a positive control for LHCGR in
western blot analyses and immunohistochemistry. Leydig cells
used for the LH bioassay were obtained from C57 male mice.
Six-week-old inbred FVB/Nico female mice (Charles River,
Saint- Germain sur l’Arbresle, France) were induced to super-
ovulate with intraperitoneal injections of pregnant mare’s serum
gonadotropin (PMSG; 3.5 IU; Intervet, Boxmeer, The Nether-
lands) followed46h laterwith an injection of 5 IUhCG (Intervet).
The mice were then mated with FVB/Nico male mice. Zygotes
were obtained on Day 1 after hCG injection. Only zygotes with
two clearly visible pronucleiwere cultured further. Embryoswere
cultured in groups of 20 or 25, incubated at 38.0 0.58C in a
humidified atmosphere of 5% CO2 in air and allowed to develop
in 50-mL droplets of M16 medium under mineral oil (Fertipro,
Beemem, Belgium) until Day 5 or Day 6. At this stage, approxi-
mately 90% of embryos had reached the blastocyst stage. To
cover the period of embryo development around their implanta-
tion (i.e. fromDay 5 to Day 10), blastocysts were further cultured
in G2V5Plus (Vitrolife, Go¨teborg, Sweden) medium. The media
were harvested and conserved for analyses every 2 days, from
Days 5 or 6 to Day 9 or 10. Some cultures were stopped to kill
embryos every day fromDay5 toDay 10.Consequently, embryos
and samples of the culture mediumwere obtained daily fromDay
5 to Day 10 andwere stored at208C until the LH radioimmuno-
assay (RIA) was performed (Table 1). Blastocysts were sonicated
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for 30 s, then the lysates were centrifuged at 10000g for 10min at
48C; the resulting supernatants were harvested immediately
before performing the RIA. Uterine horns and blood samples
from pregnant and non-pregnant mice were obtained from the
FVB/Nico female mice to study implantation sites.
Vaginal smears
Vaginal smears were prepared to determine the stage of the
oestrous cycle. The mouse vaginas were flushed with 20 mL
Dulbecco’s phosphate-buffered saline (DPBS; Lonza, Verviers,
Belgium), which was then deposited on a slide and stained with
haematoxylin–eosin (HE) and examined at200 magnification
by light microscopy.
Preparation of mouse tissues and cells
To study implantation sites and LH production during preg-
nancy, mice were killed on Day 7 of pregnancy by cervical
dislocation. Blood samples were taken and the uterine horns
were exposed by dissection. Implantation siteswere collected by
cutting the uteri on either side of each decidual swelling. The
embryos were extracted from these implantation sites. All
the implantation sites for a given female were pooled, as were
all the embryos from the same female. Implantation sites and
embryos were stored in M16 medium until the LH RIA was
performed. Blood samples were centrifuged to obtain serum,
which was stored until the LH RIA. Immediately before per-
forming the RIA, embryos and implantation sites were sonicated
for 30 s and then centrifuged at 10 000g for 10min at 48C; the
resulting supernatants were harvested for the RIA.
The Leydig cells used for the LH bioassay were obtained
from C57 mouse testes, as described by Dufau et al. (1974).
Briefly, testes were dispersed mechanically in M199 medium
(Lonza; six testes per 10mL) using sharp scissors, followed by
mixing with a magnetic stirrer at room temperature for 10min.
After filtration through nylon mesh (mesh size 100 mm), the cell
suspensionwaswashed twicewithM199medium supplemented
with 0.1% bovine serum albumin (BSA; Sigma-Aldrich,
Bornem, Belgium), 0.125mM 1-methyl-3-isobutyl-xanthine
(MIX; Sigma-Aldrich) and 20mM HEPES (Sigma-Aldrich)
immediately before the bioassay. Cells obtained using this
technique are predominantly Leydig cells, as described previ-
ously (Dufau et al. 1974; Ding and Huhtaniemi 1989).
To obtain endometrial tissue, mice were killed by cervical
dislocation and dissected to expose the uterine horns, which were
opened immediately in situ along the anti-mesometrial axis. One
horn from each mouse was frozen in Tissue-Tek (Labonord,
Templemars, France) and storedat808Cfor immunohistochem-
istry; the second horn was used for mRNA extraction and placed
in 1.5mL Hanks’ balanced salt solution (Lonza) containing
penicillin (10 000 IUmL1) and streptomycin (10 000mgmL1;
HBSS-AB). The endometrium was isolated according to the
method described by Buxton and Murdoch (1982). Briefly, the
endometrium was isolated accomplished by digesting the tissue
for 45min at 378C in 5mgmL1 collagenase 1a (Sigma-Aldrich)
diluted in HBSS-AB. The tissue was gently pipetted to disperse
the cells during collagenase digestion. Then, 3mL fresh HBSS-
AB was added to quench the reaction and the suspension was
passed through a silk filter. The filtered suspension was then
centrifuged for 5min at 360g. The pelleted cells were washed
twice with HBSS-AB and centrifuged at 360g for 5min. The
number of viable cells was then determined by Trypan blue dye
exclusion. Samples were transferred into an Eppendorf tube and
centrifuged at 360g for 5min. A volume of 500mL of RNeasy
Lysis Buffer (RLT; Qiagen, Valencia, CA, USA) containing 1%
b-mercaptoethanol (Merck, Darmstadt, Germany) was added to
the cells, which were then stored at808C until RNA extraction.
The testis and ovaries used as positive controls for western
blot analysis were obtained from BALB/c mice and were
dissected using the same protocol as used for uterine horn
removal. The dissected testes and ovaries were homogenised,
incubated in radioimmune precipitation assay buffer and stored
at 208C until protein extraction.
Toobtain thepancreas,micewerekilledbycervical dislocation
and the pancreas dissected. The excised pancreas was homoge-
nised, incubated in RLT containing 1% b-mercaptoethanol and
then stored at808C until RNA extraction.
Ovaries were treated to obtainmouse granulosa cells. Female
mice were stimulated with one injection of PMS-G (Sigma-
Aldrich; 5 IU per 0.1mL) 48 h before being killed by cervical
dislocation and dissected to expose the ovaries. Each ovary was
placed in RPMI medium (Lonza) with 1% L-glutamine (Lonza),
perforated and then incubated in 199 medium (Lonza) contain-
ing 6.8mM EGTA and 0.2% BSA (Sigma-Aldrich) for 10min.
The ovaries were then incubated in M199 medium containing
1.8mM EGTA, 0.2% BSA and 0.5M sucrose for 3min, washed
three times with RPMI–1% L-glutamine and homogenised in
RPMI–1% L-glutamine and 10% fetal calf serum (FCS). The
resulting suspension was passed through a silk filter. The number
of viable cells was determined by Trypan blue dye exclusion
and cells were resuspended in RLT–1% b-mercaptoethanol and
stored at 808C until RNA extraction.
The pituitary gland was extracted after mice had been killed
by cervical dislocation and the extract was stored in RLT–1%
b-mercaptoethanol at 208C until RNA extraction.
Radioimmunoassay for LH
The LH concentrations in 100 mL culture medium were deter-
mined using a double-antibody method and a commercially
Table 1. Number of embryos killed and used for each analysis on the days of interest
Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 Total no. embryos
LH assay 1100 1700 1400 1200 1600 1100 8100
LH bioactivity 200 400 300 400 400 400 2100
Lh RNA expression 0 500 0 0 0 0 500
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available RIA kit (mLHRia), kindly supplied by the National
Institutes of Health (Dr A. F. Parlow, National Institute of
Diabetes and Digestive and Kidney Diseases, National Hormone
and Peptide Program, Torrance, CA, USA). Rat LH-I-10 (AFP-
11536B) was labelled with 125I using the chloramine-T method
and the hormone concentration was calculated using the mouse
LH reference preparation (AFP-5306A) as the standard. Intra-
and interassay CVs were less than 4% and 7%, respectively. The
sensitivity of the assay in culturemediumwas4 pg100mL1. The
remaining culture medium and embryos were pooled according
to the day of gestation and stored at 208C until the bioassay.
Bioactivity of LH
To determined LH bioactivity, a procedure described previously
byDufau et al. (1974) andDing andHuhtaniemi (1989)was used.
Briefly, Leydig cells were seeded to obtain a final density of
50 000 cells perwell in 100mLM199medium supplementedwith
0.1%BSA, 0.125mMMIX and 20mMHEPES. The incubations
were performed in triplicate at 348C for 3 h with shaking at 150
cycles permin in a 95%O2/5%CO2 atmosphere. AnLH standard
curve diluted in M16 medium was established that contained
defined amounts of LH ranging from 15.6 to 500pgmL1 (AFP-
5306A). Each sample corresponding to a particular condition
(from Day 5 to Day 10) contained 100mL of the interstitial cell
suspension and 100mL of the LH standard or a 100-mL aliquot of
the corresponding embryo culture medium. Samples contained
an average of 40 pgmL1 LH in M16 medium or G2V5Plus, as
described above. Control samples contained a cell suspension in
M199 medium, M16 or G2V5Plus.
After incubation, the cells and culture medium were har-
vested from the wells and centrifuged at 435g for 10min. Then,
150 mL supernatant was removed from each sample and stored at
208C until the testosterone assay.
Testosterone RIA
Testosterone concentrations were determined by direct RIA
using the RIA Testosterone Direct Kit (Beckman Coulter,
Villepinte, France) according to themanufacturer’s instructions.
The RIA was performed in duplicate. The incubation was per-
formed in duplicate in a 378C water bath for 3 h. Each sample
contained 50 mL embryo culture medium collected in the bio-
assay and 500mL I125-labelled testosterone. Results are
expressed as the amount of testosterone produced by Leydig
cells after incubation with embryo culture medium.
The LH bioactivity was calculated using the testosterone
curve generated from the known concentrations of LH placed in
the Leydig cell cultures. An LH standard curve diluted in M16
medium was generated during the bioassay using defined
amounts of LH. The testosterone levels produced by the known
concentrations of LH were also determined by the RIA. The
results of the assay were used to generate a curve of testosterone
production resulting from incubation with LH. For each embryo
culture medium sample, the concentration of testosterone as
determined by the RIA was reported on this curve. The aim of
this calculation was to compare the bioactivity of the LH
produced by mouse embryos with the bioactivity of a standard
LH (AFP-5306A).
Immunohistochemistry
Uteri were embedded in Tissue-Tek and frozen at 808C. Sec-
tions (5mm) were cut and deposited on slides. The slides were
incubated for 2min in wash buffer (1/10 0.5M 50mM Tris –
5mMHCl, pH 7.6, 0.9%NaCl, 0.5%Tween 20, 0.2%NaN3) and
fixed in 10% paraformaldehyde for 10min. The slides were then
washed three times in wash buffer for 5min and blocked with
milk (1.5% diluted in DPBS) for 30min. Slides were incubated
overnight at 48C with a primary polyclonal goat anti-rat LHCGR
antibody (pAb; Tebu-Bio, Boechout, Belgium; 4mgmL1)
diluted in 50mMTris-HCl, pH7.6, and 10%NaN3. The next day,
slides were washed three times for 5min and then incubated with
a secondary fluorescein-coupled mouse anti-goat IgG Ab
(Sigma-Aldrich) diluted 1 : 50. After three 5-min washes, the
slidesweremountedwithVectashieldmountingmedium (Vector
Laboratories, Burlingame, CA, USA). Pancreas sections served
as the negative control with 40,60-diamidino-2-phenylindole
(DAPI)-stained nuclei. The negative control was established
using Ig from goat (I5256 Sigma-Aldrich). Testis sections with
Leydig cells served as the positive control.
Western blot analysis
Total cell extracts were prepared by incubating cells in radio-
immune precipitation assay buffer (50mM Tris-HCl, pH 7.4;
150mM NaCl; 1% Nonidet-P40, 1% Triton X-100; 1% sodium
deoxycholate; 0.1% sodium dodecylsulfate (SDS); 5mM
iodoacetamide; 2mM phenylmethylsulfonyl fluoride). Samples
were centrifuged at 10 000g for 30min at 48C, the supernatant
collected and frozen at 208C. Protein concentrations were
determined using the Bradford test (BioRad, Nazareth Eke,
Belgium) and 20mg protein was analysed per sample. The
extracts were concentrated under reducing conditions and
resolved by SDS–10% polyacrylamide gel electrophoresis
(PAGE) and transferred to polyvinylidene fluoride (PVDF)
membranes (Immobilon Transfer Membrane; Millipore, Over-
ijse, Belgium). The membranes were exposed to primary anti-
LHCGR rabbit pAb (1 : 1000;GB-30071;Gentaur, Kampenhout,
Belgium) diluted in wash buffer with 2% BSA. After extensive
washing, the membranes were incubated with a secondary goat
anti-rabbit antibody (1 : 1000; #7074; Cell Signaling, Danvers,
MA, USA). Signals were detected using Fujifilm LAS 4000
(FujifilmLife Science, Edison, NJ, USA). Testis cell extracts and
ovaries cell extracts from wild-type mice served as the positive
controls, whereas testis cell extracts from LH/hCG receptor-
knockout (LuRKO)mice, which were generated by disruption of
exon 11 of the Lhcgr gene (Zhang et al. 2001a), served as the
negative control. Precision Plus Protein Standard Dual Colour
(BioRad) standards were used to estimate molecular weight.
RNA extraction for RT-PCR and real-time
quantitative RT-PCR
Total cellular RNA was extracted from tissue samples
(endometrium, embryos, pancreas, granulosa, anterior pituitary
gland cells) using an RNeasy Mini Kit (Qiagen, Valencia, CA,
USA) according to the manufacturer’s instructions. Samples
were treated with RNase-free DNase (Roche, Mannheim,
Germany). The RNA concentrations of the samples were
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determined using a NanoDrop ND-1000 (NanoDrop Products,
Wilmington, DE, USA).
For RT-PCR, total RNA (50 ngmL1) was reverse transcribed
using reverse transcriptase and a Transcriptor First Strand cDNA
Synthesis Kit (Roche) according to the manufacturer’s instruc-
tions. Amplification of cDNA for RT-PCR was performed using
a FastStart Taq DNA polymerase kit (Roche) and Eurogentec
(Lie`ge, Belgium) primer pairs corresponding to the mouse Lhcgr
and Lh cDNA sequences. Primers against the b-actin cDNA
sequence were acquired from Invitrogen (Grand Island, NY,
USA). The Lhcgr, Lh and b-actin primers yielded amplified
products of 185, 259 and 250bp, respectively (Table 2).
The PCR reactions for Lhcgr, Lh and b-actin contained
1.5mM MgCl2 and 400 nM each of the forward and reverse
primers. The PCR cycling conditions for Lhcgr began with an
incubation at 958C for 5min, followed by amplification by 40
cycles of 45 s at 958C, 45 s at 59.58C and 1min at 728C. The PCR
cycling conditions for Lh began with an incubation at 958C for
5min, followed by amplification for 40 cycles of 45 s at 958C,
45 s at 608C and 1min at 728C. The PCR cycling conditions for
b-actin began with an incubation at 958C for 5min, followed by
amplification for 30 cycles of 45 s at 958C, 45 s at 558C and
1min at 728C.
The PCR products were analysed by electrophoresis on 2%
agarose gels. The product size of Lhcgr was estimated using an
EZ Load 100 bpMolecular Ruler (BioRad), whereas the product
size of Lh was estimated using an EZ Load Precision Molecular
Mass Standard (BioRad). Lhcgr was also amplified from gran-
ulosa cells (positive control) and pancreas (negative control),
whereas Lhwas also amplified from anterior pituitary gland cells
as a positive control. To confirm that the PCR products repre-
sented mouse Lhcgr and Lh transcripts, the PCR products were
subjected to sequence analysis using a 3100-Avant Genetic
Analyzer from ABI Prism (Applied Biosystems, Carlsbad, CA,
USA) by the Laboratory of Human Genetics-CHU (Liege,
Belgium). DNA contamination during the PCR was assessed
by running a sample inwhich the cDNAwas replacedwithwater.
Real-time quantitative (q) RT-PCR was used to quantify
mRNA in a BioRad iCycler according to the TaqMan method
(Holland et al. 1991). Each 25mL reaction for the housekeeping
gene 18s consisted of 100 ng þRT sample, 50% iQ Supermix
(BioRad), 5%Mix Human 18s rRNA 20* (Applied Biosystems)
and 25%nuclease-freewater (Ambion, Grand Island, NY,USA).
Each 25mL reaction for Lhcgr consisted of 100 ngþRT sample,
50% iQ Supermix, 2mM MgCl2, 200 nM each primer (Euro-
gentec), 200 nM probe (Eurogentec) and 10% nuclease-free
water (Table 2). A probe labelled with VIC (emitting fluores-
cence at 530nm) was used for analysis of 18s expression and a
probe labelled with FAM (emitting fluorescence at 490 nm) was
used for analysis of Lhcgr expression. The qPCR programme
beganwith an incubation at 508C for 2min, followedby 10min at
958C and then 40 amplification cycles. Each cycle consisted of
denaturation for 15 s at 958C followed by annealing for 1min at
59.58C. Target gene expression was determined using the DCt
comparative Ct (cycle threshold detection) method to normalise
target gene expression against that of 18s rRNA expression.
Expression of Lhcgr in granulosa cells was used to generate
standard curves (with each dilution run in duplicate) for quantifi-
cation of Lhcgr expression (dilution range: 90 000–370 pg).
Statistical analyses
Non-parametric tests were used for Lhcgr qPCR data analysis
because, in many experiments, the data covered a wide range of
values andwerenot normallydistributed.Datawere subjected to a
Kruskal–Wallis test followed by a Dunn post-test to evaluate
differences in Lhcgr expression throughout the oestrous cycle or
differences in lh expression and production by embryos in culture.
Median differences were considered significant when P, 0.05.
Parametric tests were used to evaluate data on LH expression and
productionbyembryos inculture andonLHbioactivity onLeydig
cells, and the statistical significance of the data was analysed by
one-way analysis of variance (ANOVA) with a Tukey post-test.
Mean differences were considered significant when P, 0.05.
Results
Detection of a bioactive LH signal in the murine blastocyst
at the mRNA and protein levels
To assess lh transcripts produced by the murine embryo, total
mRNA was extracted from 500 pooled mouse blastocysts and
subjected to RT-PCR. As a positive control, RT-PCR was per-
formed on RNA obtained from pituitary glandular cells. Six
days after fertilisation, lh transcription in mouse blastocysts was
examined (Fig. 1). The PCR products were sequenced and found
to correspond to Mus musculus lh (gi 930344).
Mouse LH was detected by RIA from 5–10 days after
fertilisation in blastocysts (each sample contained 100 blasto-
cysts; Fig. 2a) and in the embryo culture medium (FVB/NICO;
Table 2. Sequences of the primers used for quantitative reverse transcription]polymerase chain reaction
and the size of the corresponding amplicon
PCR, polymerase chain reaction
Primers Sequence PCR product size (bp)
lhcgr forward 50-GAT-GCA-CAG-TGG-CAC-CTT-C-30 185
lhcgr reverse 50-TCA-GCG-TGG-CAA-CCA-GTA-G-30
lhcgr probe 50-FAM-CTC-ATC-GCC-ACG-TCA-TCC-TAC-TCA-CT-TAMRA-30
lh forward 50-CAG-TCT-GCA-TCA-CCT-TCA-CC-30 259
lh reverse 50-ACA-GGC-CAT-TGG-TTG-AGT-CC-30
b-Actin forward 50-TAA-AGA-CCT-CTA-TGC-CAA-CAC-AGT-30 250
b-Actin reverse 50-CAC-GAT-GGA-GGG-GCC-GGA-CTC-ATC-30
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each sample represented LH produced by 50 blastocysts;
Fig. 2b). Themouse blastocyst LH signal remained stable within
the embryo from Day 5 to Day 9 (although a slight increase was
observed between Day 6 and Day 8), but the quantity of LH
produced and secreted by the embryos into the culture medium
increased significantly from Day 5 to Day 10.
Mouse LH bioactivitywas detected using an in vitro bioassay
to measure the production of testosterone by Leydig cells that
were stimulated with LH. The LH signal was identical to the
signal identified by RIA within blastocysts (Fig. 2c) and in
embryo culture medium (Fig. 2d ). The LH bioactivity detected
in embryos remained constant between Day 5 and Day 10 after
fertilisation. Interestingly, the bioactivity of the LH detected in
the embryo culture medium increased significantly (P, 0.001)
after 7 days of culture. Figure 2e, f shows LH bioactivity
detected in both the embryo proper and in the embryo culture
medium. The results from this assay revealed that the LH
bioactivity profile within the embryo remains constant
(Fig. 2e), whereas the LH bioactivity profile in the embryo
culturemedium exhibited a highly significant increase fromDay
5 to Day 10 (Fig. 2f ).
Experiments conducted on pregnant mice on Day 7 of
gestation resulted in the detection of an LH signal in Day 7
serum, implantation sites and embryos (Fig. 2g), with the high-
est level of LH observed in the serum.
Morphological characterisation of murine vaginal smears
To characterise the endometrial biopsies before performing
qRT-PCR, sorting criteria were established owing to the
absence of appropriate criteria in the literature. First, the mouse
oestrous cycle was characterised chronologically by perform-
ing vaginal smears on 10 BALB/c mice four times a day for
5 days. Each stage was identified by assessing epithelial cell
morphology and the presence or absence of leucocytes. Using
these criteria, the following four stages were easily identified:
(1) pro-oestrous stage, characterised by rounded epithelial cells
and a discernible nucleus (HE staining); (2) the oestrous stage,
characterised by epithelial cells that are keratinised and the
absence of a discernible nucleus; (3) a metoestrus stage,
characterised by the appearance of leucocytes among the ker-
atinised cells; and (4) dioestrus, in which leucocytes are the
major cell population in the vaginal smear (.50%) and epi-
thelial cells are again visible.
Localisation of LHCGR in endometrial tissue
Intense LHCGR labelling was observed in luminal and glan-
dular endometrial epithelium across the stages of the oestrous
cycle (Fig. 3a–d ). As expected, we did not observe any LHCGR
labelling with the anti-LHCGR pAb in the pancreas, as expected
(Fig. 3e, f ). As a negative control, we used endometrium at the
metoestrous stage incubated with goat IgG (Fig. 3g). Testis
incubated with anti-LHCGR served as a positive control.
Western blot analysis of LHCGR protein
Proteins extracted from the endometrium across the different
stages of the oestrous cycle were analysed by western blotting
using a primary pAb against rat LHCGR protein. As shown in
Fig. 4, the LHCGR protein was present at every stage of the
oestrous cycle with a protein band of approximately 60 kDa.
Protein lysates from mouse testis cells served as the positive
control, whereas protein lysates from LurKO mouse testis cells
served as the negative control. To control for gel loading,
b-actin protein levels were also assessed by western blotting
(molecular mass ,40 kDa).
Expression of Lhcgr during the oestrous cycle
To determine the presence of Lhcgr transcripts, total mRNAwas
extracted from the intact endometrium and subjected to
RT-PCR. The PCR products were analysed by electrophoresis
on a 2%agarose gel. RNAextracted from granulosa cells and the
pancreas was used as a positive and negative control, respec-
tively. DNA contamination was also controlled during PCR by
replacing cDNA with water in one sample. b-Actin was chosen
as the housekeeping gene. As shown in Fig. 5, Lhcgr tran-
scription was detected in the mouse endometrium at the four
stages of the oestrous cycle. In addition, the PCR products were
sequenced and subsequently identified as Mus musculus Lhcgr
(gi 94471503).
Quantification of Lhcgr transcripts in endometrial cells
Endometrial cells were isolated from 79 uteri to quantify Lhcgr
expression throughout the oestrous cycle. The endometriumwas
collected at each of the four stages of the oestrous cycle, namely
pro-oestrus (n¼ 16), oestrus (n¼ 14), metoestrus (n¼ 25) and
dioestrus (n¼ 24). To quantify Lhcgr transcripts, Lhcgr
expression in granulosa cells was used to establish standard
curves, with 18s used as the housekeeping gene against which
Lhcgr expression was normalised (Fig. 5c). The mean level of
Lhcgr expression was calculated for each stages of the oestrous
cycle.
Themean ( s.e.m.) expression of Lhcgr increased from pro-
oestrus (6.8 1.1; median 5.855) to oestrus (9.9 2.2; median
9.041), increased again from oestrus to metoestrus (15.0 2.2;
median 11.46) and reached a maximum at dioestrus (15.1 2.3;
median 13.72). These increases from one stage to the next were
not statistically significant (P. 0.05), but the difference
between metoestrus and pro-oestrus was significant (P¼
0.00257). In addition, a significant decrease in Lhcgr expression
was observed between dioestrus and the following pro-oestrus
stage (P¼ 0.0245).
259 bp 
1 2 3 4
Fig. 1. The lh transcripts (259 bp) were detected in mouse blastocysts on
Day 6 (Lane 4) after fertilisation. Water (Lane 1) was used as a technical
control. Themigration front of the primers appears as a fuzzy band inLanes 1
and 4. Adenohypophysis (Lane 3) served as a positive control. EZ Load
Precision Molecular Mass Standard (BioRad, Nazareth Eke, Belgium) was
used to estimate the molecular weight scale (Lane 2).











































































































































































































































































































































































Fig. 2. Quantification of LH in (a) mouse blastocysts (100 per sample) and (b) blastocyst culture
medium (50 per sample) from Day (D) 5 to D10 after fertilisation (during implantation).
(c, d) Results of the testosterone assay showing LH bioactivity from mouse blastocysts (c) and
blastocyst culture medium (d ) fromD5 toD10 after fertilisation. (e, f ) LH bioactivity determined by
the bioassay ofLHonLeydig cells formouse blastocysts (e) and blastocyst culturemedium (f )) from
D5 to D10 after fertilisation. (g) Quantification of LH expression in pregnant mice on gestation Day
7. Each sample represents one mouse for which all embryos and implantation sites were pooled. The
LH concentrations decreased in the sera and embryos between early and late day of the study,
whereas concentrations at implantation sites were stable. Data are expressed as mean  s.e.m.
*P, 0.05, ***P, 0.001.
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Discussion
The specific interaction between blastocyst-derived hCG and
endometrial LHCGR constitutes a fundamental exchange that
highlights the molecular dialogue at the maternal–fetal interface.
According to our previous observations and those of other groups,
hCG plays important paracrine roles in implantation, angiogen-
esis and immune tolerance (Perrier d’Hauterive et al. 2004, 2005;











Fig. 3. LocalisationofLH/choriogonadotropin receptor (LHCGR)protein in the cyclingmurine uterus, the pancreas
(negative control) and in the testis (positive control). Glandular (Arrow 1) and luminal (Arrow 2) epithelium labelled
with primary goat polyclonal antibodies (pAb) raised against rat LHCGR and a secondary fluorescein-coupled rabbit
pAb to goat IgG. (a) Pro-oestrus, (b) oestrus, (c) metoestrus, (d ) dioestrus, (e) pancreas incubated with anti-LHCGR
pAb, ( f ) pancreas with 40,60-diamidino-2-phenylindole-stained nuclei (Arrow 3), and (g) endometrium at the
metoestrus stage incubated with goat IgG. (h) The testis served as a positive control. Original magnification 200.
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evidence indicating that LHCGR expression peaks during the
implantation window in women and is the receptor of a specific
embryo signal (V. Gridelet, S. Berndt, M. Tsampalas, V. Geenen
and J. M. Foidart, unpubl. obs.), we have hypothesised that
LHCGR may be an important new biomarker of that crucial
period. To avoid ethical polemics inherent to the study of
implantation in human females, we have used the murine model
to explore the impact of LH–LHCGR cross-talk during implan-
tation. The presence of a bioactive LH/hCG-like signal during the
implantationwindow inmice favours thismodel because it shows
that there is great similarity between mouse and human implan-
tation. The aims of the present study were to determine whether
mice generate a bioactive LH/hCG-like signal that could have an
impact on implantation as is observed in humans and to investi-
gate and quantify endometrial LHCGRexpression throughout the
oestrous cycle in the BALB/c mouse at both the protein and
mRNA levels.
We have demonstrated, for the first time, the presence of an
LHCGR ligand/signal in mouse trophoblast cells.We have gone
on to show that the murine blastocyst expresses and produces an
LH signal very early during development, before implantation,
as demonstrated in human development by Fishel et al. (1984),
and we have demonstrated that this LH signal is clearly bioac-
tive. To our knowledge, this is the first demonstration of the
production of a bioactive LH signal by the mouse embryo. This
demonstration indicates that the mouse may be a good model in
which to study the role and impact of LHCGR signalling during
implantation. Moreover, we detected LH in vivo on gestation
Day 7 in sera, embryos and implantations sites. There was a
higher concentration of LH in the serum than in the embryos and
at the implantation sites. These results do not mean that the LH
found in the serum comes exclusively from the implanted
embryo. The majority of the LH in the serum of pregnant mice
could be from the pituitary gland before and after ovulation or
could be the result of an increase in pregnancy-related hor-
mones. Herein, we characterised the presence of an LHCGR
ligand/signal in mouse trophoblast, a question that, to date, had
never been clearly answered. We also showed that the murine
blastocyst expressed and produced an LH signal very early
during its development, just before implantation, as demonstrat-
ed before in humans (Fishel et al. 1984) and recently confirmed
by Ramu et al. (2011) as early as Day 2.We showed that this LH
signal is clearly bioactive. To our knowledge, this is the first
demonstration of the production of a bioactive LH signal by the
embryo in the murine species. Moreover, we detected an in vivo
LH signal on gestation Day 7 in the sera of pregnant mice,
embryos and implantations sites. There was a higher concentra-
tion of serum LH compared with that in embryos and at the
implantation sites. We cannot exclude the possibility that this
pattern could be explained by a potential external source of LH
(of pituitary origin, for example). However, a study by Bachelot
MW 1 2 3 4 5 6 7
Fig. 4. Expression of LH/choriogonadotropin receptor (LHCGR) inmouse
endometrium throughout the oestrous cycle (one mouse each). The LHCGR
band is located at approximately 60 kDa. Primary rabbit anti-LHCGR rabbit
polyclonal antibody and secondary goat anti-rabbit antibody were used.
Lane 1, testis from a LHCGR-knockout mouse as a negative control; Lane 2,
pro-oestrus; Lane 3, oestrus; Lane 4,metoestrus; Lane 5, dioestrus. The testis
(Lane 6) and ovary (Lane 7) from a wild-type mouse served as positive
controls. MW, molecular weight scale.
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Fig. 5. (a) Expression of lhcgr transcripts (185 bp) at different stages of the
oestrous cycle in BALB/c mice. Total endometrial RNAwas extracted from
one or two uteri at each stage (for metoestrus and dioestrus, n¼ 2).
(b) b-Actin transcripts (250 bp) served as the housekeeping control. W,
water replaced cDNA; MW, molecular weight scale; G, granulosa (positive
control); Lane 1, pro-oestrus; Lane 2, oestrus; Lane 3, 4, metoestrus;
Lane 5, 6, dioestrus; P, pancreas (negative control). (c) Quantification of
endometrial lhcgr transcripts throughout the oestrous cycle. Results show
the ratio of lhcgr/18s expression (arbitrary units). Seventy-nine mice were
used across the four stages of the oestrous cycle as follows: pro-oestrus
(n¼ 16), oestrus (n¼ 14), metoestrus (n¼ 25) and dioestrus (n¼ 24) uteri.
Black bars represent the mean for each group.
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et al. (2009) showed that female mice lacking the prolactin
receptor (PRLR) are sterile due to a failure of embryo implanta-
tion, which could be a consequence of decreased LHCGR
expression in the corpus luteum and inadequate levels of
progesterone. In that study, female mice treated with hCG
showed de novo expression of LHCGR in the corpora lutea that
was not able to reverse the implantation defect (Bachelot et al.
2009) because, in mice, only prolactin is essential for the
induction of the repression of progesterone catabolism, even if
LHR are stimulated by hCG. Together, these findings explain
the viability of the mouse KO for the LHCGR embryos (Huhta-
niemi et al. 2002): the prolactin itself and maternal pituitary LH
production allow the maintenance of sufficient progesterone
levels to maintain pregnancy.
The mouse Leydig cell assay described by Dufau et al.
(1974) and Ding and Huhtaniemi (1989) was used in the present
study to test for LH-like activity. In the male, production of
testosterone by Leydig cells is regulated by LH. As such,
testosterone production in Leydig cells exposed to LH provides
a useful, sensitive and specific method of measuring bioactive
LH levels. Our results confirmed that an LH/hCG signal is
bioactive from Day 5 after fertilisation onward and this bioac-
tivity increases significantly in the embryo culture medium after
Day 7; however, LH bioactivity remains constant in the embryos
during this time. Immediately upon synthesis, LH is secreted
by the embryonic cells. It is therefore not surprising to find a
constant level of LHbioactivity in the embryos.We also assessed
LH bioactivity (LH or hCG-like) produced and secreted by
mouse embryos. Although LH bioactivity remains constant
within the embryo, the LH bioactivity accumulates markedly
within the embryo culture medium over time.
The murine oestrous cycle is divided into the following four
stages: pro-oestrus, oestrus (or ovulation), metoestrus and
dioestrus (Allen 1922). These stages can be distinguished by
characterisation of cells in vaginal smears (Allen 1922), the
appearance of the vagina (Champlin et al. 1973) or histological
modifications of the endometrium and vagina (Allen 1922; Putti
and Varano 1979). The stages of the oestrous cycle have been
described in the rat (Kaasjager 1969). We rigorously redefined
each stage of the mouse oestrous cycle by examining vaginal
smears to more accurately identify the stages, which is essential
for characterising the endometrial biopsy. Vaginal smears were
obtained every 5 h from BALB/c mice and stained with HE, as
described by Allen (1922). This step is crucial because inaccu-
rate characterisation of the endometrium can entirely skew the
quantification of LHCGR expression and, hence, identification
of the implantation window.
Studies performed over the past decade indicate that LHCGR
is expressed in the human endometrium (Licht et al. 2003; Rao
and Lei 2007); however, these findings are in contrast with those
reported by Stewart et al. (1999). Zhang et al. (2001b) reported
finding Lhcgr transcripts in the mouse reproductive tract.
However, until now, this gene expression has not been quanti-
fied throughout the oestrous cycle. Using immunohistochemis-
try, we characterised LHCGR localisation in the endometrium
and demonstrated intense labelling of the endometrial epithelium
at every stage of the oestrous cycle. The labelling was particu-
larly bright at the luminal surface of endometrial gland epithelial
cells and in the lumen.This observation is very important, because
this region of the endometrial surface facilitates binding of
embryo signals such as the LH ligand. Pertinently, the endometri-
al epithelium is the first tissue encountered by the hatched embryo
and LHCGR epithelial expression may reflect a pivotal role for
this receptor during the adhesion phase of implantation. In
addition, we used western blot analysis to examine LHCGR
protein expression and found a 60-kDa protein corresponding
to the LHCGR protein present throughout all stages of the
oestrous cycle.
Using RT-PCR, we examined endometrial Lhcgr expression
using mRNA extracted at pro-oestrus, oestrus, metoestrus and
dioestrus. Our findings confirmed and extended the results
reported by Mukherjee et al. (1994) that indicate that Lhcgr
transcripts are present in the endometrium and are expressed
throughout the oestrous cycle. Real-time RT-PCR quantifica-
tion with the TaqMan method was used to quantify the level of
Lhcgr expression throughout the cycle. We found that Lhcgr
transcripts increased throughout the oestrous cycle from a
median of 5.855 arbitrary units (AU) at pro-oestrus to
9.041AU at oestrus to 11.46AU at metoestrus, peaking at
13.72AU at dioestrus. Indeed, the stages with higher Lhcgr
expression correspond to the theoretical time of murine embryo
implantation. After dioestrus, the expression level of Lhcgr
dropped significantly back down to the pro-oestrus level of
the next cycle. Our qRT-PCR results confirmed and extended
findings in the mouse model reported by Bonnamy et al. (1990),
who observed a cyclic variation in LHCGR binding to radi-
olabelled hCG in the rat endometrium. The increased Lhcgr
expression at the time of implantation provides further support
for a possible role of LHCGR signalling at the maternal–fetal
interface during embryo implantation in mice. Our results also
agree with those from a study by Chudgar et al. (2005), who
found that LuRKOmice were not able to become pregnant after
hormonal substitution or after orthotopic transplantation of
wild-type ovaries. The contribution of uterine LHCGR signal-
ling to the infertility of LuRKO mice was demonstrated by one
group (Lin et al. 2005); however, conflicting results were
published by Pakarainen et al. (2005), who were unable to show
that orthotopic transplantation of wild-type ovaries into an
LuRKOmouse resulted in impaired implantation. Nevertheless,
although LHCGR has been identified previously in murine
endometrium (Mukherjee et al. 1994) and an embryonic LH/
hCG-like signal has been detected throughout the pregnancy in
the conceptus, placenta (Wide and Wide 1979) and plasma
(Gidley-Baird 1977), these findings were never confirmed or
have been the subject of controversy in the field (Roberts et al.
1996). In addition, to date the endometrial LHCGR ligand has
never been identified in mouse blastocysts. The debate as to the
importance of LHCGR for implantation has remained open
because of the uncertainty as to whether the embryo secretes
an LH/hCG-like signal as a ligand for endometrial LHCGR. Our
results clearly confirm that the endometrium expresses LHCGR
and demonstrate that the embryo is capable of communicating
with endometrium through its production of a bioactive LH/
hCG-like signal.
Our findings strongly suggest that the LHCGR system is
complete at the time of implantation, with both the hormone and
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receptor being strongly expressed. In the future, an investigation
of the binding of LH to the LHCGR should be undertaken to
provide a better understanding of the LH-mediated cell signal-
ling events that occur in the endometrium. It would also be
interesting to identify the specific cells within the blastocyst
(including the embryonic disc and associated membranes) that
express LH mRNA and protein. A very critical experiment that
would be interesting to perform would be to use a Cre/Lox
system or a short interference RNA system to inactive gene
expression of Lhcgr in the endometrium. This could elucidate
definitively the controversy surrounding endometrial LH–
LHCGR cross-talk at the time of implantation.
In conclusion, the results of the present study demonstrate
LHCGR expression by BALB/c mouse endometrial epithelium
with increased expression at the time of implantation and further
argue for a possible contribution of LHCGR function in the
implantation process. We have also demonstrated that a highly
bioactive LH signal is produced by embryos at the time of
murine blastocyst implantation. On the basis of a role for
LHCGR as the specific receptor for a blastocyst signal and
the expression profile of Lhcgr during the oestrous cycle,
we propose that an LH–LHCGR interaction may mediate
cross-talk between the embryo and the endometrium during
the implantation process. Better understanding of LHCGR
signalling-mediated events during implantation will provide
us with a more comprehensive picture of the normal human
implantation process. Finally, this understanding will provide
insight into the impact that hCG therapy has on medically
assisted procreation in human patients with implantation, endo-
metrial or embryonic disorders.
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